Johnson & Johnson Reports Q2 2021 Results
New Brunswick, N.J. (July 21, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to patients and consumers around the world, in addition to advancing our pipeline with new product launches and regulatory submissions. These ac...
Source: Johnson and Johnson - July 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Hear RPS England Chair Thorrun Govind speak to the BBC about hay fever and cetirizine shortages
RPSEnglish Pharmacy Board Chair Thorrun Govind featured on BBC Radio 5 Live and BBC radio stations across the country yesterday, June 24, after pharmacists reportedshortages of cetirizine.
The antihi (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 25, 2021 Category: Drugs & Pharmacology Source Type: news
Johnson & Johnson Reports 2020 Fourth-Quarter and Full Year Results
New Brunswick, N.J. (January 26, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. “Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout the COVID-19 pandemic,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs. These efforts, and our commitment to families around the world as the largest broad-...
Source: Johnson and Johnson - January 26, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Quzyttir (cetirizine)
Title: Quzyttir (cetirizine)Category: MedicationsCreated: 10/2/2020 12:00:00 AMLast Editorial Review: 10/2/2020 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - October 2, 2020 Category: Allergy & Immunology Source Type: news
Antihistamines May Help Calm COVID-19 Cytokine Storm Antihistamines May Help Calm COVID-19 Cytokine Storm
Dual histamine-receptor blockade with cetirizine and famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19, according to a new study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Johnson & Johnson Reports 2020 First-Quarter Results:
New Brunswick, N.J. (April 14, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2020. The Company also announced earlier today that its Board of Directors declared a 6.3% increase in the quarterly dividend rate, from $0.95 per share to $1.01 per share. At the new rate, the indicated dividend on an annual basis is $4.04 per share compared to the previous rate of $3.80 per share. “With Johnson & Johnson’s century-plus history of leading in times of great challenge, we are mobilizing our resources across the Company in the fight against the COVID-19 pandemic,” said Alex Gorsky, C...
Source: Johnson and Johnson - April 14, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news
Is It Allergies, The Flu Or The Coronavirus? How To Tell The Difference
(CNN) — The coronavirus has infected more than 100,000 people worldwide. With all of the news of event cancellations, empty flights and health precautions (wash your hands!), it’s natural that people may get a little anxious every time they feel a tickle in their throat or the beginnings of a bad cough.
While the coronavirus is certainly something to take seriously, the chances of any individual person getting it are still low. But if you’re wondering whether that stuffy nose could end up being a worst case scenario, CNN talked to Dr. Greg Poland, a professor of medicine and Infectious diseases at the May...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 11, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Coronavirus Source Type: news
Zerviate (Cetirizine Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 18, 2020 Category: Drugs & Pharmacology Source Type: news
Quzytiir (Cetirizine Hydrochloride Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 12, 2019 Category: Drugs & Pharmacology Source Type: news
Quzytiir (Cetirizine Hydrochloride Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 16, 2019 Category: Drugs & Pharmacology Source Type: news
FDA OKs Cetirizine Injection (Quzyttir) for Acute Urticaria FDA OKs Cetirizine Injection (Quzyttir) for Acute Urticaria
Cetirizine hydrochloride (10 mg/mL) intravenous injection is for treatment of acute urticaria in adults and children 6 months of age or older.FDA Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - October 15, 2019 Category: Internal Medicine Tags: Dermatology News Alert Source Type: news
